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ABSTRACT 
Ethylene (ethene) is the essential ripening hormone for climacteric plants, and 
consequently its detection and quantification is of considerable interest to the horticulture 
industry. Its detection however is a non-trivial pursuit, traditionally requiring expensive 
and inaccessible instrumentation that fail to provide in vivo information about ethylene. A 
ruthenium based fluorescent probe for the selective detection of ethylene has recently been 
developed, and it was envisioned that this probe could be made biocompatible by encasing 
it within a protein scaffold making it an artificial metalloenzyme. To this end biotinylated 
N-heterocyclic carbenes (NHCs) were synthesized, which can be appended onto the 
ruthenium probe. Efforts towards the expression and purification of the protein scaffold are 
also here reported. 
Mycofactocin (MFT) is a ribosomally synthesized and post-translationally 
modified peptide (RiPP) hypothesized to function as a redox cofactor in bacteria, 
particularly the Mycobacteria genus, which includes M. tuberculosis. In order to further 
elucidate the function of MFT and its associated proteins, a synthetic route was desired to 
the small molecule. A viable synthetic route to MFT, pre-MFT (PMFT) and other structural 
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1. ARTIFICIAL METALLOENZYME ETHYLENE DETECTION 
 
1.1 Introduction: Ethylene 
 
1.1.1 Role within plants 
 
Within plants and some bacteria, ethylene acts as the critical hormone within 
several developmental processes and stress responses, such as germination, senescence, 
ripening, abscission, and cell apoptosis, among others.1 Many of these processes can be 
initiated by ethylene both endogenously or exogenously sensed, critical especially due to 
ethylene’s central role in the ripening of climacteric (meaning ethylene dependent) fruits 
such as apples, cantaloupes, bananas, and tomatoes.2 All of these exhibit a steep increase 
in the amount of ethylene synthesis directly preceding the fruit ripening process, and 
consequently take on the characteristics of becoming ripe; loss of chlorophyll, formation 
of pigments, flavors and aromas, and softening of flesh. This occurs quite naturally, 
however in modern agriculture the ripening process must be controlled and monitored in 
order to prevent the spoilage of fruits en route to the consumer. While there are 
technologies to scrub ethylene from controlled atmospheres, many of these are toxic and/or 




Within plants, biosynthetic ethylene is produced from methionine in 3 steps: 1) the 
conversion of methionine to S-adenosyl-L-methionine (SAM) by SAM synthetase, 2) the 
formation of 1-aminocyclopropane-1-carboxylic acid (ACC) from SAM  by ACC synthase 
and release of methylthioladenosine (MTT), and finally 3) the conversion of ACC to 
ethylene by ACC oxidase (Figure 1.1)1, 7  
Following its production, ethylene is sensed by a family of membrane-associated 
receptors, all of which contain some copper cofactor which most likely coordinates to 
ethylene directly, although this has not directly been confirmed as discussed in further 
detail further in this chapter.8-10 This presumed binding leads to a change in conformation 
of the receptor, modulating associated proteins and triggering downstream effects in a 
signaling cascade. How these interactions achieve downstream specificity or influence 
ethylene affinity of the receptor is largely unknown, since there is a possible feedback loop 
regulating receptor’s binding.9 The agroeconomic impact of ethylene makes understanding 
its signaling all the more important to understand. While there is considerable interest 
leveraged towards this study, there is a lack of available tools to probe ethylene within 




Figure 1.1 Ethylene Biosynthetic pathway 
 
1.1.2 Methods of detection  
 
Ethylene is an exceedingly simple molecule, especially when compared against 
other molecules that elicit similar large cellular responses. This lack of complexity makes 
its detection and quantification at physiological concentration (10 ppm to 10 ppb) 
exceedingly difficult. Due to the demand from the horticulture industry there have been 
many developments in terms of detection, however of those advancements there are still 
relatively few new methods. While there are other methods, 4 of the primary techniques 
will be discussed here, those being gas chromatography,  optical sensing, chemoresistive, 
and chemodosimeters.  
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The most broadly applied method of gaseous detection by far and away is gas 
chromatography (GC). Premised on the ability to separate compounds based on their 
individual ability to interact with the mobile/stationary phase, as well as the unique boiling 
point of the compound, GC has the added advantage of being able to detect multiple species 
in a single run, and quantitatively determine their relative abundance. The hopefully 
separated compounds are quantified by some detector, such as mass spectrometry (MS), 
flame ionization detector (FID), etc. Separation ability and detection limit compared to 
instrument size has traditionally been the limit for GC with regards to on-site monitoring 
and analysis,11 however in recent years there have been technological advancements 
allowing for miniaturized GC instruments. For example, Sklorz et al recently used a 
miniature GC (µGC) to detect ethylene to a resolution of a few ppm using a SnO2 
chemoresistive detector, however this still required a pre-concentration apparatus 
appended onto the instrument.12, 13  
Infrared spectroscopy (IR) has also been utilized for detecting gaseous ethylene. 
Irradiating a chamber containing the analyte and tracking the absorbed incident light at a 
characteristic wavelength, there are generally two categories of optical sensors, dispersive 
and non-dispersive. Nondispersive instruments operate by selecting the wavelength of 
interest, modernly by means of optical fibers, and are usually inexpensive. This wavelength 
selection results in a high threshold of detection and limited sensitivity, constraining their 
application for ethylene detection. On the other hand, dispersive instruments, utilizing 
either a prism or grating, or especially those using a laser as a light source, can be very 
sensitive with low limits of detection (less than 1 ppb)14, 15, but their on-site application has 
been limited by prohibitive costs.16 Similar to GC, there have been marked improvements 
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in IR detector miniaturization, such as utilizing a preconcentration step17 or refining the 
broadband source to allow for better wavelength discrimination using microcrystalline 
diffraction.18, 19 
Another field that has been used fairly extensively for ethylene detection are 
chemoresistive sensors, which are premised upon the change in the electrical 
conductivity/dielectric constant following exposure to the analyte. The material for this 
technique varies greatly, ranging from metal oxides, conductive polymers, or carbon 
materials.20 For ethylene, the most common material are metal oxides, such as the SnO2 
detector discussed with regards to the µGC.12, 13 Simply explained, many semiconducting 
metal oxides are n-type, and exposure to air will coat the surface with oxygen molecules 
acting to withdraw electrons. This bulk reduction of electrons from the semiconductor 
forms a space charge region, consequently also forming a surface potential (Schottky 
barrier). Interaction with a reducing gas, such as ethylene, leads to a release of electrons 
and lowering of the Schottky barrier, which can be measured and recorded as a change in 
the conductivity.20, 21 Interaction with an oxidizing gas (such as NO2 or O3) with increase 
the barrier and result in a reduction of current.18 
Using this strategy there have been a plethora of chemoresitive sensors that use SnO2, 
as well as WO3.18 These can show limits of detection down to 1 ppm, and are comparatively 
inexpensive to manufacture. One drawback however is selectivity, a critical issue that is 
still being addressed.22 There are other technologies being pursued and utilized towards 
gaseous detection, such as single walled carbon nanotubes, amperometric sensors, and 
gravimetric sensors, however those are discussed in further detail in comprehensive 
reviews.11, 16, 18  
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A recent approach to ethylene detection is the use of fluorescent molecules that 
interact with ethylene in such a way to either increase in fluorescence (turn on) or to 
decrease in fluorescence (turn off). The remainder of this section will be dedicated to this 
approach.  
1.1.3 Ethylene chemodosimeters/probes 
 
Fluorescent probes and chemodosimeters, the primary difference being the 
reversibility of the reaction leading to a response (reversible vs. irreversible respectively), 
all require two primary components, those being the recognition element and the signaling 
element. The recognition element must have some mechanism by which it can bind or 
recognize the specific target, and the signaling element is what produces the measurable 
signal. It is the recognition element that poses the greatest difficulty for fluorescent probe 
design for ethylene, since it lacks the nucleophilic and electrophilic handles that other 
probes rely upon.23 The singular handle that ethylene does possess is an unhindered π-
system, which can interact with various metals.  
Within the biosynthetic pathway and recognition of ethylene, the key component is 
the copper cofactor residing within ETR1. Containing a single copper site, ethylene is 
thought to coordinate directly to the metal, with a Kd = 2.4 × 10-9 M.24, 25 The explanation 
for this tight binding is provided by the Dewar, Chatt, and Duncanson model, which 
describes two interactions between a metal and an olefin ligand consisting of both σ-
donation and π- accepting interactions. σ-donation is the donation of electron density from 
the olefin π-bond into an unoccupied orbital on the metal. Simultaneously, the overlap 
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between a filled orbital on the metal and the π-antibonding orbital of the olefin leads to 
further donation, resulting in a net π-bond between the ligand and the metal (Figure 1.2).26  
 
Figure 1.2 Dewar-Chatt-Duncanson hypothesis 
 
 This ability of ethylene to interact with metals has provided nature the necessary 
handle to detect ethylene, and using that same handle several groups have created 
fluorescent probes that can report the presence of ethylene. The first example of this was 
developed by Burstyn and coworkers, who impregnated a poly(vinyl phenyl ketone) 
(PVPK) film with AgBF4 and were able to observe the PVPK’s quenching upon exposure 
to ethylene.27 This was explained to be the preferential interaction of the Ag (I) with 
ethylene. In later works, they modified that system with other polymers and silver salts, 
increasing their sensitivity and selectivity.28  
Utilizing a ‘turn-on’ method, Esser and Swager used diphenylacetylene and 
diphenylbutadiyne, which were quenched by the interaction of a stable Cu(I) complex. 
Upon exposure to ethylene however, the coordination between the alkyne and the copper 
complex was disrupted and the alkyne was no longer quenched.29 Like Burstyn, the Kodera 
group utilized a coordinated Ag (I) to develop their system, where the silver ion also served 
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to quench the pendant anthracene moiety.30 Upon interaction with ethylene this 
coordination was disrupted, and an increase in the fluorescence was observed.  
1.1.1.1 Ruthenium base ethylene chemodosimeters/probes 
 
In 2018 a novel method of ethylene detection was reported by the Michel group, 
similar to other reports in regards to taking advantage of an ethylene-metal interaction, but 
unique in terms of how that interaction effects the metal and the reporter moiety.31 Up to 
this time, all of the ethylene-metal reporters relied upon the transient interaction of ethylene 
with the metal. With a decrease in ethylene concentration there would be a commensurate 
decrease or increase in the fluorescent response, depending on the system being discussed. 
This holds several advantages of course, such as iterative experiments and the ability to 
reuse the developed system, however this also severely limits the detection level, such that 




Figure 1.3 Previous ethylene probes 
 
The interaction of olefins and ruthenium differs from that of Cu (I) and Ag (I) in 
that following the coordination of the olefin’s π-system, a 2+2 cycloaddition can occur 
between the newly associated olefin and the one that was already bound. This creates a 
metallacyclobutane, from which either a productive (forward) or unproductive (reverse) 
2+2 cycloreversion occurs. If it had proceeded in the forward direction, the carbons 
comprising the original olefin will now comprise the methylidine complex, reformed and 




Figure 1.4 Generalized olefin metathesis reaction  
 
The interaction between the olefin and the metal center is influenced by the steric 
and electronic character of the olefin, to a such a degree that several different classes have 
been developed to predict their reactivity. Of the 4 types, outlined in Figure 1.5, ethylene 
is the prototypical example of a type 1 olefin, indication that a ruthenium catalyst should 
be selective for ethylene preferentially over other alkenes. Additionally, there are several 
different ruthenium-based catalysts commercially available, with varying degrees of water 
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stability and rates of reactions. The predominant commercial species are shown below 
(Figure 1.5).  
 
Figure 1.5 Major Grubbs Catalysts and Olefin types, as characterized by reactivity 
to Cross metathesis 
 
With this in mind, a complex derived from a Hoveyda-Grubbs 2nd generation was 
synthesized bearing a BODIPY fluorophore on the phenyl substituent (Figure 1.6). The 
proximity of the metal to the fluorophore is such that the BODIPY is quenched, however 
upon interaction with ethylene and subsequent cross metathesis, expulsion of the 
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fluorophore occurs. No longer being influenced by the heavy atom effect, a marked 
increase in fluorescence is observed.31 While there was some background turn on observed, 
limits of detections were 13 ppm and 9 ppm for BEP-4 and BEP-5 respectively.  
 





These limits of detection were obtained by injecting ethylene into a sealed cuvette 
while the probe was dissolved in dry toluene. This represented a major improvement for 
small molecule detection of ethylene, as those values are well within the range of 
physiological ethylene concentration within climacteric fruit.  
Additionally, both probe variants were tested for their ability to detect 
endogenously produced ethylene in physiological conditions. To achieve this the probes 
were incubated with HEK239T cells and Chlamydomonas reinhardtii, and subsequently 
exposed to ethylene produced directly from an adjacent chamber containing a ripe 
banana/mango. Unsurprisingly, it was observed that the large lipophilic probe was 
observed to localize to the outer cell membrane in both systems, outlining the cells when 
visualized with confocal microscopy.31 
Later that same year, Sun and Huang utilized a similar technique by appending 
various fluorophores onto a 1st generation Grubbs catalyst.32 Two unique BODIPY’s were 
added, as well as a pyrene-type fluorophore (Figure 1.7). Utilizing the less stable Grubbs 
1 catalyst, the probes were primarily tested within a DCM solution, however they were 
able to achieve detection levels of 0.9 ppm,32 which bodes well for the ability of other 




Figure 1.7 G1 type ruthenium-based ethylene probes developed by the Huang group 
 
Despite these advances, there are marked disadvantages to using metal catalysts for 
ethylene detection within cellular systems, the most poignant being water compatibility. 
With the exception of the Michel report, organic solvents have been heavily featured in 
probe evaluation, often using solvents that are toxic and immiscible for biological function. 
Additionally, none of the probes so far mentioned have been used to test endogenously 
produced ethylene within the cellular system, relying on exogenous sources regardless of 
its production. In order to test endogenously produced ethylene biologically, there has been 
a singular report proposing to address this issue by using an artificial metalloenzyme to 
encase the metal probe.33 This is discussed in more detail following a brief review of 
artificial metalloenzymes.  
 
1.2 Introduction: Metalloenzymes 
 




Comprised of folded polypeptide chains, enzymes are the most important type of 
catalysts for biological transformations, with oftentimes unmatched specificity and 
catalytic efficiency. In order to enact these transformations, many enzymes require some 
non-protein cofactor, such as metal ions or metal clusters, such that approximately 1/3rd of 
human proteins require some metal cofactor for full functionality.34  
The functions of metalloenzymes range an impressive span of reactivity and are 
responsible for catalyzing many of the indispensable processes in nature, such as 
photosynthesis, water oxidation, nitrogen fixation, and respiration. Metals such as Fe and 
Cu are well known for their roles as the prevailing redox metals, however there are many 
examples of enzymes making use of other metals such as Mg, Zn, Ca, and Mo to enact 
variegated chemical reactions (Figure 1.8) 
For example, aerobic respiration is dependent upon the iron containing heme 
proteins for the transport and storage of oxygen. Nitrogenases utilize a Fe/Mo ion cluster 
with bridging sulfides to catalyze nitrogen fixation,35 and the oxygen-evolving complex of 




Figure 1.8 Natural metalloenzymes 
 
These are key examples of metalloenzymes that catalyze thermodynamically 
unfavorable reactions that are not only crucial for life, but are exceedingly difficult to 
reenact outside of the enzymatic realm of chemistry.  




Within the field of synthetic chemistry, transition metal catalysts have been utilized 
to enact a range of chemical transformations, such as C–H functionalization, cross-
coupling, and olefin metathesis. With a relatively large substrate scope, the challenge with 
many of these small molecule homogenous catalysts has been dictating selectivity (regio-, 
chemo-, or stereo-) of the reaction. This control has been afforded primarily by modulating 
the primary coordination sphere; typically, the ligands that interact directly with both the 
metal center and the substrate.38  
 
Figure 1.9 Enzyme vs homogenous catalysis  
 
In addition to producing catalysts that impose selectivity via the primary 
coordination sphere, there have also been several examples of catalysts changing ligands 
distal to the metal center, which is the secondary coordination sphere.39 This operates using 
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weaker non-covalent interactions, such as hydrogen bonding or steric interactions that 
impose directionality and control, yet these systems require extensive engineering and are 




Figure 1.10 Bioconjugation methods. a) Dative, b) covalent, c) supramolecular  
 
1.1.1.3 Early artificial metalloenzymes 
 
The first report of a protein being used as a scaffold for a non-native metal came 
with Kaiser and Yamamura’s 1976 report of substituting the Zn (II) of carboxypeptidase 
A (CPA) with a Cu (II) center.41 Initially a hydrolytic enzyme known to exhibit peptidase 
and esterase activity, when the native metal center was removed via dialysis and replaced 
with a Cu(II) ion all hydrolytic activity was lost but the ability to oxidize ascorbic acid to 
dehydroascorbic acid was gained. While copper itself is a very common metal for natural 
metalloenzymes, by substituting the metals they were able to confer the ability to catalyze 
a different form of chemistry, albeit a known hydrogenation. 
Shortly after that in 1978, Whitesides and Wilson utilized a completely different 
approach by anchoring a Rh(diphosphine) within avidin.42 By using the high affinity of 
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biotin for avidin, they were able to accomplish the asymmetric hydrogenation of several 
substrates due to the inherent chiral environment (Figure 1.11).  
1.1.1.4 Dative 
 
Following these two initial results, there was a period where no further research 
was considered regarding ArMs, most likely due to the difficulty exploring ArM variations 
in comparison to the burgeoning growth of small molecule homogeneous catalysis. 
Following the advent of recombinant protein expression and single point mutations 
however, ArMs could be generated with modified residues and metallic handles installed. 
Distefano and Davies exemplified this by covalently linking a 1,10-phenanthroline ligand 
using an installed cysteine residue within the cavity of adipocyte lipid binding protein 
(ALBP) to bind to Cu (II).43 With this system in place, the ArM could catalyze the 




Figure 1.11 Early artificial metalloenzymes; Kaiser and Whitesides 
 
1.2.2 Artificial metalloenzyme assembly 
 
Deliberately installing Lewis basic amino acids with which to coordinate some 
unnatural metal is the least utilized method, most likely due to the large degree of 
variability that comes with reorganizing the first coordination sphere. Despite that, there 
have been several examples, such as Popp and Ball’s example of a peptide bound 




Figure 1.12 Popp and Ball’s artificial metallopeptides 
 
More common is to utilize the naturally occurring binding site for a metal, and to 
change out the naturally occurring metal for a different one. This is the strategy that was 
utilized by the Kaiser group with carboxypeptidase A but has been most efficiently used 
with carbonic anhydrase. The naturally occurring metalloenzyme catalyzes the hydration 
of carbon dioxide and dehydration of bicarbonate within the vascular system, utilizing a 
coordinating Zn (II) ion.45 The tri-histidine active site has proved labile to substitution to a 
variety of different divalent metals, such that following the sequestration of zinc using 2,6-
pyridinedicarboxylate the Kazlauskas and Soumillion groups have installed both Mn (2) 
and Rh (2) into the system.46-49  
1.1.1.5 Covalent Anchoring 
 
The third strategy is to covalently anchor the metal center to form a novel active 
site, typically by modifying a biomolecular host, to which the metal catalyst can then be 
attached via several methods. The first of this type of semi-synthetic enzymes was prepared 
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by Kaiser in which the sulfhydryl of Cys25 within the binding pocket of papain was 
alkylated with different flavins, resulting in increased oxidoreductase activity towards N-
benzyl-1,4-dihydronicotinamide (Figure 1.13). A very similar strategy was utilized by de 
Vries by decorating the Cys25 with a phosphorous ligand, which could then be complexed 
with [Rh(COD)2]BF4, affecting a hydrogenation ArM 50, 51 (Figure 1.13). Salmain installed 
a Ru (II) catalyst within the active site, creating a catalytic Diels-Alder ArM-papain.52  
 




These methods utilize an already existing reduced cysteine residue which can be 
easily decorated with different electrophilic linkers. This relies however on an accessible 
cysteine residue, which often has some catalytic function within a binding site. Since the 
catalytic function of ArMs do not need to depend on the original function of the protein 
itself, other properties can then be prioritized, such as organic solvent tolerance or 
thermostability.53 Cysteine residues for this purpose have been expressed in recombinant 
proteins, such as in Distefano’s example above, with the major caveat that the reactive 
residue is uniquely existent to achieve site-selective modification. Utilizing an installed 
cysteine moiety within a protein scaffold is a common approach54-57, however disrupting 
molecular function or folding makes the approach difficult in some proteins. Other, more 
biorthogonal approaches have also been utilized, such as the use of strain promoted azide-
alkyne cycloaddition (SPAAC)58, 59 to generate dirhodium ArMs. Making use of prolyl 
oligopeptidase (POP) containing a p-azido-L-phenylalanine, the Lewis group has been able 




Figure 1.14 Installing unique amino acids 
 
This approach enables a greater variety of proteins to be explored, as azide 
functionalities have been successfully integrated into a variety of proteins without 
deleterious effects on form and function.  
1.1.1.6 Supramolecular Anchoring  
 
The final major strategy used to anchor a metal moiety within a biomolecular host 
is supramolecular anchoring, in which a ligand or linker with a strong and specific 
molecular recognition is attached to the metal center. A prime example of this is the 
streptavidin/biotin system pioneered by Whitesides, a strategy that has been recapitulated 
by Ward. Biotin has an unusually high affinity for streptavidin (Ka = 1015 M-1)60, and can 
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easily be added to a wide variety of ligands. The inherently chiral environment of the biotin 
binding pocket, referred to the vestibule, transfers chiral information naturally to a wide 
variety of reactions.  
The initial ArM catalyzed asymmetric hydrogenation reported by Whitesides 
showed moderate enantiomeric excess,42 however the approach used by Ward focuses on 
modulating both the primary and secondary coordination spheres, coined a chemogenetic 
optimization strategy. The primary coordination sphere, consisting of the ligand and linker, 
can be altered through standard chemical synthetic methods, and the secondary 
coordination sphere by site-directed mutagenesis and directed evolution. With this strategy, 
the Ward group has applied the SAV system to allylic alkylations,61 dihydroxylations,62 
asymmetric hydrogenations, 63-67 and other reactions (Figure 1.15).68-75 
While the biotin-(strept)avidin system has been utilized extensively by the Ward 
group, there have been other supramolecular approaches explored. One unique approach is 
provided by the Roelfes group, who took advantage of the hydrophobic cavity formed 
between the dimer subunits of Lactococcal multidrug resistance regulator (LmrR).76, 77 
Within this cavity they were able to implant a Cu(II) complex, relying upon two tryptophan 




Figure 1.15 Various examples of Ward's work embedding metals within 
strept(avidin), with and without biotin conjugation 
 
Within a buffered solution this was able to catalyze a Friedel-Crafts alkylation 
between an indole and imidazole with decent enantioselectivity.77 Using the same system, 
they then modified the area around the pivotal tryptophan residues, and were able to install 
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a heme cofactor which could then catalyze the cyclopropanation of various styrenes with 
mild enantioselectivity.78 
 
Figure 1.16 Other supramolecular anchoring strategies 
 




Embedding a synthetic metal center within a protein lends several potential 
advantages to the catalytic activity. Early examples capitalized on the induced chiral 
environment to catalyze a variety of asymmetric reaction. Further examples take advantage 
of that same environment to not only induce chirality, but to also exclude solvent from the 
transition state and slow the rate of byproduct formation. Most early examples utilize only 
the protein itself, such that following expression the protein was purified, and all 
subsequent reactions took place within a buffer, usually with some organic cosolvent to 
solubize the organic substrates. The full potential of ArMs however is realized when they 
are utilized within the complex biological system of a living system. This however has 
proven to be a not trivial task, since many metal cofactors are inhibited by cellular 
components, the principle of which being glutathione.79, 80 Metal incorporation into the 
cell, let alone to the correct scaffold, are all complicating factors. 
Despite these challenges, there have been several examples that have successfully 
generated ArMs within living systems. The first example of this was with Song and 
Tezcan’s generation of an artificial metallo-β-lactamase, which when expressed within the 
periplasm of E. coli enabled the bacteria to survive treatment with ampicillin.81 First 
mutating cytochrome cb562 to form a self-assembling tetramer, then generating variants 
with coordinating residues (His/Glu) such that catalytic Zn sites would be formed, an ArM 
that could hydrolyze ampicillin was formed. Using a N-Terminal translocation sequence, 
the ArM could mature within the periplasm of E. coli and granted mild ampicillin resistance 
(0.8-1.1 mg/L).81 
Using the biotin/streptavidin system, Jeschek and Ward generated a ruthenium 
containing ArM which could catalyze ring closing metastasis (RCM) in vivo.79 
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Biotinylating a Hoveyda-Grubbs 2nd generation catalyst, then incubating that with E. coli 
expressing periplasmic streptavidin resulted in the formation of the active ArM localized 
in the periplasm. By using the fluorescent molecule umbelliferone as their model substrate, 
they could screen several thousand mutants in a few days, allowing them to use saturation 
mutagenesis to develop a high activity RCM ArM. In subsequent studies, they have utilized 
this method of secreting streptavidin into the periplasm to catalyze transfer hydrogenations 
with an iridium catalyst.82 
There have also been several reports of functional ArMs being expressed on the 
surface of live cells, the majority of which utilize the same biotin/streptavidin system 
described above. Heinisch and Ward expressed SAV with a Lpp/OmpA leader sequence, 
which results in SAV secretion into the periplasm, followed by anchoring to the outer 
membrane. Using a biotinylated ruthenium catalyst, they were afforded an artificial 
deallylase, whose activity they could track using an uncaged fluorescent aminocoumarin.83 
Surface expressed ArM’s haven’t just been achieved with E. coli, but with other organisms 
as well. Utilizing the same deallylase catalyst described above,83 an electrophilic N-
hydroxysuccinimide ester was used to anchor the ArM onto the cell wall of 
Chlamydomonas reinhardtii.84 Finally, there is a singular report of ArM use within 
mammalian cells. Okamoto and Ward used a cell-penetrating linker to pull both the 
ruthenium and SAV into HEK-293T cells, where acting as a deallylase it uncaged 
triiodothyronine (T3), a thyroid hormone that upregulated an installed gene switch.85 
As previously mentioned, there is a very recent example that generated a 
metalloenzyme that catalyzes the olefin metathesis between ethylene and a fluorescent 
molecule. By doing this, the Tanaka group was able to increase the water solubility of the 
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lipophilic complex, and additionally protected the precious metal catalyst from deleterious 
water-soluble interactions, most notably glutathione and other small molecular weight 
thiols. Using a three-component probe based on a Hoveyda-Grubbs catalyst (HGC), 7-
diethylaminocoumarin (DEAC), and 4-((4-(Dimethylamino)phenyl)azo)benzoic acid 




Figure 1.17 Tanaka's example of an ethylene sensing artificial metalloenzyme 
 
DEAC is the fluorescent molecule, and is appended to the mesityl backbone of the 
HGC, on which the olefin component is decorated with the DABCYL moiety, which is 
known to be a quencher for coumarin based dyes.86 Using this system, they were able to 
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record down to 27 ppm for their LOD dissolved in THF, but more significantly were able 
inject a metal based ethylene probe into the plant cellular environment.33  
This was an elegant solution to place the ruthenium cofactor within the living 
environment of the cell, and unlike many of the artificial metalloenzymes that have been 
covered herein, there is no specific bioconjugation method used in the design of the probe. 
Instead, the authors utilized albumin as their enzyme, which while bereft of a specific 
binding site that could be used for supramolecular binding, does possess of a large 
hydrophobic pocket in which the hydrophobic probe could localize.87 While this was 
effective in sequestering the probe and protecting it from glutathione,33 this system requires 
using isolated protein and probe to premix prior to any cellular usage, which greatly limits 
the ability to use this system for in vivo. This is in contrast to Ward’s example of in vivo 
metathesis, in which the biological scaffold (streptavidin) is expressed and stays within the 
cell, and the metal cofactor with a bioconjugation linker (biotin) is added to the cells. This 
two component system has the benefit of actual in vivo usage, an attractive goal for ethylene 
detection.  
While the Tanaka manuscript was published after the commencement of this thesis’s 
primary project, the shortcomings of that probe serve to highlight what this project’s goals 
were. Combining the known ability of the ruthenium probes BEP4 and BEP5 to detect and 
quantify ethylene in a variety of environments, with recent advances presented by the Ward 
group in in vivo transition metal chemistry, it was hoped to prepare an ethylene detecting 
artificial metalloenzyme. Efforts towards that goal are presented herein.  




The Bio-BEP system with the N-Heterocyclic Carbene (NHC) bearing the biotin 
linker has been shown to be the most efficacious system for olefin metathesis,79 so those 
were the initial targets to synthesize. While significant effort does go into decorating the 
ruthenium core of the probe, the primary synthetic hurdle was the synthesis of the biotin-
NHC conjugate. On the NHC itself, there are two unique sites that can be used for biotin 
attachment, those two being on the mesityl group 70 or on the backbone of the heterocycle 
71. It has been reported that the difference in the two sites results in a difference in catalytic 
ability of the streptavidin/Ru conjugate by Ward,88 however since our goal is the singular 
reaction of ethylene with the ruthenium to release the fluorophore, it was decided that both 




Figure 1.18 a) Possible Bio-BEP’s and their biotinylation points and b) broad 
retrosynthetic route to the mesityl substituted complex 
 
The precursor to most metal-NHC complexes is an imidazolium salt, such as is 
shown in 72. While the synthesis the Bio-BEP is novel, the synthesis of the imidazolium 




Reacting first mesidine with oxalyl chloride in a 1:2.2 ratio yields the acyl chloride 
in a 53% yield (Figure 1.19). This is smoothly reacted with 4-Bromo-2,6-dimethylaniline 
to yield diamide 73. The reduction of 73 to the diamine is a challenging reduction, requiring 
rigorously degassed toluene and fresh borane dimethyl sulfide to accomplish the reaction 
in reasonable yield. The detail about using degassed toluene was not known when this route 
was first attempted, which resulted in many failed attempts to reduce the diamide. 
Following alternative reaction screenings (see below), this route was eventually revisited, 
and degassed solvent used, to afford 74 in 38% yield.  
 
Figure 1.19 Ward’s original approach to the mesityl substituted NHC, with 
averaged yields  
 
Subsequent Rosenmund-von Braun reaction, reduction, and protection of the amine 
were accomplished in yields similar to those reported by the Ward group to give 75. 
Condensation of diamine to the imidazolium salt results in a difficult to purify salt, however 
following extensive trial and error the NHC precursor 72 can be prepared in 90% yields. 
The pivotal reduction was not optimized until several alternative routes were 
attempted. A continual hinderance in the synthesis, even following the optimization of the 
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dimethyl sulfide borane reduction, was the continual low yields achieved at the end of the 
synthesis, such that even Ward’s reported yield after 7 steps was a 9% yield, an undesirable 
amount considering its importance in later steps. 
 
Figure 1.20 Direct amidation approach using ethyl chlorooxoacetate 
 
Seeking to reduce the length of the synthesis and bypass difficult steps by using a 
convergent approach, an amidation strategy was first explored, with 76 being generated 
following reaction with ethyl chlorooxoacetate. In all instances no conversion to diamide 
was observed, even with the inclusion of base or exploring different solvent systems. Due 
to the sterically hindered amine of the mesityl group, regular amidation to 77a-c simply 
wasn’t feasible on a useful timescale. Knowing that, activating the ester then attempted.  
With ester 76 in hand, carboxylic acid 78 was easily accessed, and with modified 
aryl amine 79a-c amide coupling using DCC proved moderately successful to give 80a and 
80c. With a route to a more decorated diamide, further reduction steps were attempted, and 
summarily failed to give 81a or 81c. Astringent conditions were required for borane 
complexes to reduce diamides, and hydride species did not possess the required reactivity, 
especially due to the potentially chelating ability of the diamide. In the case of the Boc 
protected amine 80a loss of the Boc group was typically observed under both reductive 




Figure 1.21 Amide coupling strategy 
 
In an attempt to circumvent the difficult diamide reduction entirely, the ethyl chain 
of the backbone was installed using bromoethanol giving the amimoethanol. From here the 
alcohol was converted into a more labile group with either an Appel reaction to install an 
iodine in 83a-c, or simply mesylated with methanesulfonyl chloride to give 82a-c. 
Disappointingly, all attempts to encourage the SN2 to failed to give 84a-c, 
regardless of leaving group, solvent, base, or R-group identity. Following successive 
failures in reducing the diamide, more intensive reduction protocols were researched, and 
it was found that generating diborane in situ via NaBH4 and BF3*OEt2 had been efficacious 
in reducing similar diamides.89 Additionally, diborane has been reported to reduce aryl 
nitriles with ease, so it was hoped that reacting 85 would result in the triple reduction of 
the diamide. Using thoroughly degassed THF, an almost complete reduction was observed 
via NMR after 12 hours of reflux, which following separation yields an oil, which without 




Figure 1.22 SN2 installation of imidazole backbone 
 
Following optimization of the diamide reduction, a convergent approach was used 
to synthesize the NHC precursor. Forming acyl chloride 87, which is reacted with aryl 
nitrile 88 to form 89 in an 86% yield. Reduction and protection of the diamide gives 90 in 
a high yielding reaction, which can be efficiently ran in a 10 mmol scale reaction. 
 
 





Figure 1.24 Modified convergent approach to mesityl substituted NHC 
 
Condensation with neat triethyl orthoformate leads to the imidazolium salt 91, 
which can be readily purified using iterative solvent-solvent recrystallizations. This 
constitutes a 43% yield over 4 steps to the NHC precursor, as opposed to the 9% yield 
accomplished using the reported methodology.  
 
Figure 1.25 Generation of imidazole substituted NHC 
 
The synthesis of the imidazole substituted NHC proved significantly more facile 
than that of the mesityl substituted NHC. Allyl amine is first dibrominated, which can 
undergo two subsequent substitutions when heated extensively in neat mesidine to give 92, 
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albeit with significant aziridine based byproducts. The primary amine is Boc protected in 
high yield, and the resulting white powder is condensed in neat triethyl orthoformate to 
give the imidazolium salt 93.  
With both of the imidazolium salts in hand, the next question became how to link 
those onto the ruthenium metal. As shown in Figure 1.26, there are two general strategies 
to append NHC’s both symmetrical and unsymmetrical onto a metal center, such as Ru. 
The first and most common strategy is the use of a strong base, such as potassium tert-
butoxide or potassium hexamethyldisilane (KHMDS), to generate the carbene in situ 95. 
This can then readily undo go a ligand exchange with a tricyclohexyl phosphine to yield 
the Grubbs two type complex 96.  
Since the generation of the carbene often necessitates the use of a glove box, an 
alternative route is the installation of an adduct of some form. The imidazolium salt 94 can 
form adducts using chloroform, other metals such as silver and gold, or even with 
carboxylates 97. The adducts are typically readily purified by chromatography, and can be 
carried into the next reaction, in which the stronger NHC-Ru bond results in a ligand 




Figure 1.26 General strategies to attach the NHC to the ruthenium center 
 
Making use of a biotin for the bioconjugation of the NHC into a protein requires 
the use of either streptavidin or avidin, both of which are comprised of 4 active monomers. 
Both proteins have been used successfully by the Ward group, as well as others, however 
the majority of these groups were not concerned with the potential problems of using a 
tetrameric protein with fluorescent molecules. To that end, we turned to using a monomeric 
form of streptavidin (MSA), which had been minimally mutated to prevent the monomers 
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from associating together while maintaining the characteristically high binding affinity for 
biotin.  
 
Figure 1.27 MSA for biotinylated probe use, with possible experiments 
 
Developed by Sheldon Park,90 the gene is commercially available through 
KeraFast. As such, the target gene was first amplified from pRSET-MSA and periplasmic 
tag pelB added using PCR, then digested with NdeI and XhoI and ligated into target vector 
pET23a(+). Following the purification of pET23a-MSA2, the plasmid was transformed 
into competent cell lines (β-10, BL21,T7-Xp). Following induction with isopropyl β-d-1-
thiogalactopyranoside (IPTG) however, no viable protein was observed on SDS-PAGE 
following purification. This lack of expression resulted in screening several vectors 




Following several iterations of plasmid construction without apparent protein 
production, an alternative approach using a different periplasmic tag was approached. The 
OmpA leader sequence has been reported to work efficacious within similar systems, so 
that route was explored next. Due to the small size of the monomeric streptavidin, 
combined with the necessity of appending both a HIS tag and an OmpA leader to the 
sequence, it was decided that the entire insert would be generated by assembly PCR. Using 
primers 1-5 the gene was assembled containing a C-terminus OmpA sequence and a N-

















Following confirmation of insert weight by agarose gel, the insert was then ligated 
into pET21, pET24, and pET28 vectors, each of which was subsequently transformed into 
BL21-pLysE and T7 express bacteria. Each vector/cell combination was then used to 
 
 44 
inoculate 1L of LB containing the appropriate antibiotic, which was then induced with 
IPTG when the OD600 was 0.6-0.9. Cells were harvested after 12 hours of shaking at 18˚C, 
and the cell pellet was sonicated, centrifuged, and the lysate was loaded onto a Ni-NTA 
His-Trap column. The column was washed with buffered 20 mM imidazole, and the protein 
was eluted with 200 mM imidazole. The fractions were analyzed by SDS-PAGE, by which 
it was observed that the pET24a-BL21-pLysE system produced a protein of the correct 
weight. This was collected and frozen without further purification.  
1.4 Conclusions and future work 
 
Two NHC’s bearing biotin have been successfully made, as have their precursors 
for further reactions. These biotinylated NHC’s will be appended onto a Grubbs 1 catalyst, 
from which point it should be facile to attach the styrene BODIPY, forming the Hoveyda-
Grubbs type probe. With two handles in different locations, the probe itself will be in 
different environments within the protein scaffold. On route to those NHCs, several 
significant problems were encountered and overcome, most appreciably with the discovery 
of the triple reduction using in situ diborane. This constitutes a significant improvement to 
the synthesis of unsymmetrical NHCs, since that is one of the methods by which chiral 
environments may be imposed upon a metal center.  
Progress was also made in the production of the protein to be the scaffold of the 
probe, monomeric streptavidin. A unique periplasmic export tag was appended using 
assembly PCR, and initial results look promising for the expression of the protein. If 
correctly being formed, the protein can be easily purified by conventional methods, and 
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utilized for further experimentation with biotinylated probes. With this technology in hand, 
the in vivo characterization of ethylene and its pathways can be further elucidated.  
1.5 Experimental 
 
2-(mesitylamino)-2-oxoacetyl chloride:  
 
To a chilled solution of dry toluene (450 mL) was added oxalyl chloride (23.2 mL, 270 
mmol, 2.7 eq.). A solution of 2,4,6-Trimethylaniline (14 mL, 100 mmol, 1 eq.) in toluene 
(150 mL) was added dropwise via cannula over a period of 80 minutes. The solution was 
stirred for 2 hours at 0˚C, following which the solution was filtered through a Buchner 
funnel, and the filtrate volatiles removed in vacuo (caution: oxalyl chloride readily pulled 
off). This crude material was triturated with petroleum ether, and the precipitate collected 
to yield a hygroscopic white fluffy solid. (Yield 50%, 11.1g)  The spectrum matches 
previously reported spectrum. 
1H NMR (500 MHz, CDCl3) δ 7.98 (s, 1H), 6.96 (s, 2H), 2.32 (s, 3H), 2.22 (s, 6H). 
4-amino-3,5-dimethylbenzonitrile 
 
4-bromo-2,6-dimethylaniline (20.0 g, 100 mmol, 1 eq.) and copper(I) cyanide (19.7g, 220 
mmol, 2.2 eq.) were suspended in NMP (260 mL) and heated to 160˚C for 18 hours. After 
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cooling to room temperature, the reaction was quenched with the addition of a 1:1 solution 
of NH3:H2O (30 mL) and stirred for 30 minutes. This was filtered through a Celite plug 
and extracted with EtOAc (3x) and the organic layers were washed extensively with brine. 
For <20 mmol scale reactions, simple chromatography (DCM) affords product as a light 
pink solid. For 20mmol> reactions bulb to bulb distillation was found to be the most 
effective purification method, yielding product as a light pink solid. (Yield 67% and 35%) 
The spectrum matches previously reported spectrum. 
1H NMR (500 MHz, CDCl3) δ 7.17 (s, 2H), 4.19 (s, 2H), 2.15 (s, 6H). 




The acyl chloride (8.42 g, 37 mmol, 1 eq.) was dissolved in dry DCM (120 mL), and cooled 
to 0˚C. In a separate flask, the nitrile (5.42 g, 37 mmol, 1 eq.), triethylamine (5.2 mL, 37 
mmol, 1 eq.), and DCM (35mL) were combined, and added to acyl chloride over 30 
minutes, then the reaction mixture stirred at room temperature overnight. Et2O is added to 
the reaction mixture, and the resulting solid collected. The precipitate was washed several 
times with Et2O and 1 
M HCl, then dried to afford the product as an off white solid. (Yield 73%) 






Diamide (6.71 g, 20 mmol, 1 eq.) and NaBH4 (4.54 g, 100 mmol, 6 eq.) were added to a 
flame-dried round bottom flask equipped with similarly dried condenser and charged under 
N2. Thoroughly degassed dry THF (100 mL) was added and the reaction cooled to 0˚C. 
BF3*OEt2 (21 mL, 160 mL, 8 eq.) was added dropwise, then following the violent 
evolution of gas the reaction was brought to reflux for 36 hours. The reaction was quenched 
by the addition of 4:1 MeOH/HCl (35 mL) at 0˚C, then the reaction mixture was evaporated 
to dryness. The residue was then resuspended in 1 M NaOH and extracted with Et2O. The 
organics were washed with water, then brine, and dried with Na2SO4. Evaporation of 
solvent yielded a viscous light-yellow oil, which can be used without further purification. 
The spectrum matches previously reported spectrum. 
1H NMR (500 MHz, CDCl3) δ 6.97 (s, 2H), 6.86 (s, 2H), 3.76 (s, 2H), 3.24 – 3.14 (m, 4H), 
2.33 (s, 6H), 2.30 (s, 6H), 2.26 (s, 3H), 1.75 – 1.56 (m, 2H). 
tert-butyl 4-((2-(mesitylamino)ethyl)amino)-3,5-dimethylbenzylcarbamate 
 
Diamine (6.23 g, 20 mmol, 1 eq.) was dissolved in dry degassed DCM (12 mL), then cooled 
to 0˚C. Boc2O (4.36 g, 20 mmol, 1 eq.) and DMAP (244 mg, 2 mmol, 0.1 eq.) were added, 
then the reaction was allowed to warm to room temperature over 3 hours. The reaction was 
extracted with DCM, washed with water, then dried with Na2SO4. The crude product was 
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concentrated onto silica and purified by chromatography on silica gel to afford the product 
as a viscous dark yellow oil. (44% over 2 steps). The spectrum matches previously reported 
spectrum. 
1H NMR (500 MHz, CDCl3) δ 6.94 (s, 2H), 6.86 (s, 2H), 4.75 (s, 1H), 4.21 (d, J = 5.8 Hz, 




Into a round bottom flask equipped with a condenser was combined diamine (2.6 g, 6.32 
mmol, 1 eq.), degassed triethyl orthoformate (21 mL, 126 mmol, 20 eq.), and anhydrous 
NH4Cl (350 mg, 6.31 mmol, 1 eq.) were combined. This was heated to 120˚C for 16 hours, 
after which the majority of the volatiles were removed by vacuum distillation. The resulting 
gummy solid was triturated sequentially with EtOAc (3x), Et2O (3x) and Pet. Ether (3x), 
following which no further color was observed to be removed by solvent. The sticky solid 
was then dried on high vac with occasional passes of a flame (the compound is very solvent 
sticky). This yielded a crunchy bubbly solid which was easily powdered with a glass stir 
rod and was pure product. (Yield 74%) The spectrum matches previously reported 
spectrum. 
1H NMR (500 MHz, CDCl3) δ 9.63 (s, 1H), 7.10 (s, 2H), 7.00 (s, 2H), 5.06 (s, 1H), 4.60 
(s, 4H), 4.27 (d, J = 6.2 Hz, 2H), 2.47 (s, 6H), 2.44 (s, 6H), 2.32 (s, 3H), 1.48 (s, 9H). 
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13C NMR (126 MHz, CDCl3) δ 160.25, 156.06, 141.56, 140.41, 135.61, 134.96, 131.75, 
130.27, 129.98, 129.93, 128.04, 79.58, 51.88, 51.76, 43.79, 28.37, 21.04, 18.19, 18.02. 
2,3-dibromopropan-1-aminium bromide 
 
Allyl amine (4.5 mL, 60 mmol, 1 eq.) was added into Di H2O (18 mL) at 0˚C, then HBr 
(5.1 M sln in acetic acid, 13 mL, 66 mmol, 1.1 eq) was added dropwise. Br2 (4.6 mL, 90 
mmol, 1.5 eq.) in DI H2O (18 mL) was added dropwise. This was stirred for 4 hours, during 
which the ice bath was allowed to warm to room temperature. The solvent was removed in 
vacuo, and the red solid triturated with ice cold methanol. The white crystals were collected 
and washed minimally with methanol. The red filtrate was concentrated, and the red 
crystals triturated with cold methanol to yield the white crystals, a process that was repeated 
several times to yield the white crystalline product. (Yield 68%) The spectrum matches 
previously reported spectrum. 
1H NMR (500 MHz, D2O) δ 4.53 (td, J = 9.5, 8.8, 4.1 Hz, 1H), 3.98 (dd, J = 11.0, 4.4 Hz, 
1H), 3.80 (dd, J = 10.8, 9.0 Hz, 1H), 3.74 (dd, J = 14.1, 2.8 Hz, 1H), 3.39 (dd, J = 14.1, 
9.6 Hz, 1H). 





Dibromide salt (10 g, 33 mmol, 1 eq.) was charged in a round bottom flask under N2, then 
mesidine (60 mL, 440 mmol, 13 eq.) was added. The solution was stirred for 16 hours at 
120˚C, and then was cooled to room temperature. Much of the mesidine was then removed 
by distillation in vacuo at 85˚C, and the dark brown residue was dissolved in Et2O. This 
was washed with 2 M NaOH, then H2O and brine, and subsequently dried with Na2SO4. 
Following concentration the viscous brown oil was taken to a silica gel column, where the 
remaining mesidine was eluted with 40% EtOAc/Hex, then the product was eluted with 
10% MeOH/DCM, yielding a dark brown oil. (Yield 15%) The spectrum matches 
previously reported spectrum. 
tert-butyl (2,3-bis(mesitylamino)propyl)carbamate 
 
Triamine (1.37 g, 4.2 mmol, 1 eq.) was dissolved in degassed DCM (10 mL) and cooled to 
0˚C. To this was added Boc2O (0.918 g, 4.2 mmol, 1 eq.) and DMAP (5 mg, 0.4 mmol, 0.1 
eq). This was stirred for 1 hour at 0˚C, and brought to room temperature over 2 hours. 
Following the indication of starting material consumption by TLC, the reaction mixture 
was washed with H2O and brine, then dried with Na2SO4. The product was obtained as a 
white powder following purification by chromatography (10% EtOAc/Hex). The spectrum 






Triamine (1.63 g, 3.8 mmol, 1 eq.) was placed in a round bottom flask equipped with reflux 
condenser, then newly sparged triethyl orthoformate (9.6 mL, 57.5 mmol, 15 eq.) was 
added. NH4Cl (215 mg, 4 mmol, 1.05 eq.) was added, then the reaction set to 120˚C for 
16h. After cooling to r.t, most of the triethyl orthoformate was removed by either simple 
distillation or simply in vacuo. The resulting orange gummy solid was triturated with Et2O 
and the precipitate collected via vacuum filtration. This was washed several times to yield 











2.1.1 Natural products 
 
Natural products make up a massive breadth of the small molecules that are known 
to be biologically active. The importance of these compounds are wide reaching, as is 
highlighted by the significant roles of natural products in cancer and infectious disease 
treatments, among many others. In addition, the unique frameworks that make the 
compounds efficacious serve as a platform for further drug discovery. Indeed, roughly 47% 
of small molecule chemotherapeutics are direct natural products, and 26% are derivates of 
natural products.91 This in comparison to the single de novo drug approved for similar 
usage (as of 2007) paints the utility of natural products with stark contrast.  
The biosynthetic pathways that lead to these compounds lead to several different 
classes, the four most pertinent being terpenoids, alkaloids, polyketides, and non-ribosomal 
peptides.   
The terpenoid class makes used of either isopentyl diphosphate and dimethylallyl 
diphosphate as starting materials, however from those two simple starting materials 
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originates drugs such as paclitaxel (Taxol) 1 and eleutherobin 2 (Figure 2.1).92 For scale, 
over 55,000 different terpenes have been isolated acting in diverse functional roles.93 
 
Figure 2.1 Examples of terpenoid natural products 
 
Alternatively, the alkaloid class uses a wide scheme of different building blocks to 
achieve the complicated structures that characterize the class. Since many of the alkaloids 
are derived from amino acids, they have access to the many chemical moieties that 
comprise the natural pool. Key to their structure is the presence of a nitrogen atom, 
typically within some heterocyclic system.94 This can be observed just by the classes that 
alkaloids are divided into, which are indoles, quinolines, isoquinolines, pyrrolidines, 
pyridines, pyrrolizidines, and tropanes to name the most prominent.95 The diversity within 
the structures is predictably echoed by a diversity in physiological effects: psychotropic, 
anesthetic, analgesic, antimitotic, antibacterial, anti-inflammatory, and antitumor among 
many others have all been observed.96  Well known alkaloids include caffeine 4, nicotine 




Figure 2.2 Well known alkaloids 
 
While these two classes are far from the only sources of natural products, they serve 
to illustrate the breadth of chemical ingenuity that biosynthetic pathways have evolved. 
While the four major classes are classically recognized, other biosynthetic routes that have 
been highlighted by the advance of genomic technology, such as ribosomally synthesized 
and post-translationally modified peptides.  
2.1.2 Ribosomally synthesized and post-translationally modified peptides 
(RiPPs) 
 
Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a 
recently discovered and growing class of natural products. The synthesis of many RiPPs 
must begin with the translation of the gene cluster, producing not only the precursor peptide 
but also the dedicated post translational modifying enzymes. On the precursor peptide 
itself, there is often a leader sequence located on the N-terminus of the peptide, followed 
by a core region on which the majority of the associated modifying enzymes will act 
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upon.99 The leader sequence serves as a recognition element, and is generally 
proteolytically cleaved off at some point during the RiPP synthesis.100 (Figure 2.3).  
 
 
Figure 2.3: Generalized RiPP biosynthetic pathway 
 
There are upwards of 20 different classes of RiPPs, with most of the classes 
delineated by the structural features of the product, as well as the biosynthetic 
manipulations used to achieve that product.100 Classes include Lanthipeptides, linaridins, 
thiopeptides, phallotoxins, and sactipeptides, among many others.100, 101 Representative 
members from some of these families are shown in Figure 2.4, however for the purpose of 
this dissertation no further exploration into those families is warranted. From these 
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representative molecules it can be observed that not only are they quite large in comparison 
to other natural products, but most retain their peptide bonds, reminiscent of their peptide 
origin. There are several RiPPs that don’t follow those broad observations, being quite 
small and lacking peptide bonds. It is this class and its representative members that shall 









There are only a few of these small molecule RiPPs, such they consist of their own 
class, rather than being subdivided into structural features or machinery as other classes 
are. Major representatives of this class are pantocin A, the thyroid hormones T3 and T4, 
and pyrroloquinoline quinone (PQQ). Pantocin A is an inhibitor of L-histidinol phosphate 
aminotransferases in Pantoea agglomerans, and is comprised a modified tripeptide core 
(Figure 2.5).  
 
Figure 2.5 Proposed biosynthetic pathway of Pantocin A 
 
Originating from a 30-residue precursor peptide, the Glu-Glu-Asn motif is 
expressed along with three ORFs.102 The paaA gene catalyzes the double dehydration and 
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decarboxylation of the adjacent glutamate residues, and the paaB gene encodes a Fe 
containing oxygenase, serving to catalyze the final dehydrogenation to 13.103 The final 
ORF, paaC is speculated to encode for a transmembrane efflux pump.102, 103 Following 
action by peptidases the functional molecule is released and exported, where it acts to 
inhibit enteric bacteria, particularly in nutrient deprived conditions.  
One of the major small molecule RiPPs characterized to date is pyrroloquinoline 
quinone (PQQ). Serving as a small molecule redox cofactor within a variety of Gram-
negative bacteria, it can be utilized within a non-glycolytic ATP producing pathway.104 In 
contrast to other RiPPs known to serve as redox cofactors, PQQ is synthesized as a discrete 
molecule from precursor peptide PqqA. Within the PQQ gene cluster itself, there are 5 
strictly conserved genes that serve to modify the glutamate and tyrosine side chains that 
form PQQ. The gene cluster is annotated as pqqABCDEF/G, where pqqA encodes the short 
(20-30 AA) precursor peptide (Figure 2.6). pqqB and pqqC encode for hydrolases and 
oxidases respectively, pqqD is the recognition element, pqqE encodes for the radical SAM 
enzyme PqqE, and PqqF/G is a peptidase.105 
Following translation, PqqD acts to bring the glutamate and tyrosine residues into 
proximity along with PqqE. The SAM  catalyzes the C-C bond formation between the ortho 
position of the phenol ring and the glutamate residue though radical proton abstraction.106 
The peptidases PqqF/G then cleave the remaining residues of the precursor peptide, leaving 
the two linked amino acids as a discrete molecule.106, 107 The tyrosine ring is oxidized by 
PqqB, leading to a ring closing event to form AHQQ.108 This molecule is then acted upon 
by PqqC to facilitate another ring closing event and the oxidation of the fused ring systems 




Figure 2.6 Proposed biosynthetic pathway of PQQ 
 
With the over 1000 bacterial genomes111 characterized, there have been several 
lucrative attempts to highlight novel biological systems through bioinformatic studies. 
Since RiPPs are often characterized by the conserved arrangement of their post-
translational proteins, the pathways can sometimes be predicted from sequencing data. This 
is especially powerful considering that many RiPPs are synthesized in response to some 
environmental trigger, the isolation of such a novel product falling to chance or exhaustive 
screening efforts. Bioinformatic studies and genome mining studies have led to the 
discovery of novel pathways that otherwise would have been remained hidden.101, 112, 113 
One such study, using a radical SAM system similar to the one found in the biosynthesis 
of PQQ as a focus point found a well conserved C-terminal motif which could feasibly be 
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a RiPP.114 This gene cluster has since been found to produce a small molecule that has been 
titled mycofactocin (MFT).  
2.1.3 Mycofactocin 
 
Even though the gene cluster is found in over 600 unique species115, the exact 
molecular function of MFT is yet unknown, but there are several possible functions that 
have been implicated. The same study that identified the MFT cluster also proposed that 
MFT could participate as a redox cofactor, since it was found that several redox active 
genes are dependent upon the pathway.114 This was corroborated by the finding that MFT-
associated dehydrogenases with a bound NADH did not allow the diffusion or turnover of 
the nicotinamide cofactor, not until the inclusion of a strong non-natural redox mediator 
2,6-dichlorophenolindophenol (DCPIP), which indicates that MFT could be acting as a 




Figure 2.7 Proposed biosynthetic pathway of Mycofactocin 
 
The biosynthetic pathway of MFT consists of a 6 gene cluster, labeled as 
mftABCDEF, representing the precursor peptide along with the possible post-
translationally modifying enzymes (Figure 2.7). MftA is the 31 amino acid precursor 
peptide, and MftB is thought to contain the recognition element, which binds and directs 
MftA. MftC catalyzes first the SAM-dependent oxidative decarboxylation, and then a 
subsequent SAM-dependent 5-exo-trig cyclization to form lactam MftA*.117-119 MftE 
hydrolyzes the lactam in an iron dependent fashion, leaving the free molecule AHDP.120 
This is then acted upon by MftD, which catalyzes the oxygen dependent deamination of 
ADHP to form premycofactocin (PMFT) (Figure 2.8). This α-ketoamide forms the redox 
center that was originally hypothesized, with a 2e-/2H+ mechanism and an E1/2 = -255mV, 




Figure 2.8 Function of MftF, and possible structures of MFT 
 
The final enzyme, MftF, has a yet unclarified function within the biosynthesis of 
MFT. Initially hypothesized to act as a glycosyltransferase,122 a single study using 
metabolomics has identified oligioglycosides with a mass difference that corresponds to 
PMFT.123 They hypothesized that MftF decorated the phenolic alcohol of PMFT with β-
1,4-glucan chains, leaving the redox active α-keto amide moiety in place.123 This was not 
done with purified MftF however, and it is likely that glycosylation isn’t the only story of 
MFT. The transmembrane domain of MftF and biologically relevant redox potential hint 
to a possible function in metabolism, however this will have to be address in further studies.  
It has been found that the redox homeostasis of M. smegmatis is reliant upon the 
expression of the MFT gene cluster, as well as the ability  to acclimate to alternative carbon 
sources, such as small chain alcohols or cholesterol.124-126 This indicates that the MFT 
genes, and presumably its product, are important for the survival of M. tuberculosis. As a 
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pathway that produces a small molecule, there are opportunities to pursue MFT analogues 
as inhibitors of the pathway, which is especially pertinent considering the possible role of 
MFT in the virulence of M. tuberculosis. 
The isolation of PMFT was pivotal in proving the role of MftD, as it allowed for 
not only the assigning of mass spectrum data, but also allowed for structural assignment 
based on 1H NMR, 13C NMR, COSY, HMBC, and HSQC data. This isolation of PMFT 
was an involved process, requiring several liters of growth media in conjunction to using a 
synthetic MftA with a 13C labeled valine and tyrosine, which was used through reactions 
with MftB, MftC, MftE, MftD, leading to a completely 13C labeled PMFT. This effort was 
necessary to simply obtain the resolution required for a 13C experiment. Further studies 
using PMFT or PMFH2 necessitated a synthetic route, one that allowed for appreciable 
yields while also granting access to possible analogs. The focus of this chapter is the 
synthesis of PMFT and PMFH2.  
 
2.2 Synthesis of PMFT 
 





Figure 2.9 Previous attempt to PMFT 
 
The synthesis was first attempted by Dr. Richard S. Ayikpoe of the Latham lab, 
who first accessed the nitroethyl benzene with a Knoevenagel condensation with p-
methoxy benzaldehyde and nitroethane in high yield. This was followed with a facile 
reduction of the alkene with NaBH4 to give the unsaturated nitroethyl. The β-addition to 
the acrylate was achieved in a 30% yield, then the resulting ester was reduced using zinc 
dust with concentrated HCl. Upon reduction to the amine, the proximity of the nearby ester, 
aided by the Thorpe-Ingold effect, quickly induced cyclization to form the lactam in decent 
yield. The amide was smoothly protected in a 65% yield. The next challenge was the 
installation of the α-hydroxy group. Bis(trimethylsilyl)peroxide has been used to install α-
hydroxy groups,127 so this route was first explored. The enolate was generated using LDA, 
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and silyl peroxide added. This yielded a complex mixture of compounds, which following 
successive failures to purify led to simply trying to oxidize the presumed alcohol. The 
oxidation however failed, reacting significantly with the benzylic position to yield 
carboxylic acids. It was at this point that this project was resumed by the author.  
 
2.2.2 Synthesis of Mycofactocin  
 
Since both the reactions leading up to the nitroethyl benzene were high yielding, no 
attempt was made to further increase the yield. However, the subsequent β-addition 
required some optimization as it was early within the synthetic steps. It was known that the 
use of a long chain tetra-alkyl ammonium salt as a phase-transfer catalyst aided the speed 
of the reaction, since under normal conditions the rate of addition would be exceedingly 
slow. Following the reported conditions of 1:1 nucleophile: electrophile with one 
equivalent of TBAF in THF gave decent conversion (30%) after 48 h at 40˚C. In an attempt 
to increase the yield, several variations of the reaction were explored, such as increasing 
the temperature, including a non-nucleophilic base, or increasing the molar equivalents of 
the ester. None of these variations seemed to increase conversion, as monitored by NMR. 
Indeed, after observing a 30% conversion after 48 hours, then a 55% conversion at 72 hours 




Figure 2.10 β-addition screening 
 
It was hoped that with the reduction of the nitro group to a nucleophilic amine, the 
proximity of the ester would lead to the formation of a 5 membered lactam. The 2 methyl 
groups would aid in the rapidity of the reaction as well, given the Thorpe-Ingald effect 
sterically influencing the carbonyl carbon towards the nascent amine. With that goal in 
mind, several options of reducing agents were reviewed. Wanting to avoid reducing agents 
that could deleteriously react with an amide, LiAlH4 was discarded. NaBH4 alone likely 
wouldn’t be able to reduce the nitro group without the addition of some Lewis acid, or 
converting it into a more potent hydride species (LiBH4) or into diborane as was done in 
the previous chapter. Reviewing the literature and available chemicals, more classical 
reductions such as Zn/HCl, Pt/C, and Raney Nickel were attempted. While the use of Zn0 
and concentrated HCl was a route that was purported to achieve the necessary reduction,128 
attempts to recreate that success were summarily met with failure and the production of an 
excess of side products. Both palladium on carbon and Raney Nickel were then attempted 
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with a balloon of hydrogen gas, however no conversion was observed and starting material 
recovered.  
 
Figure 2.11 Hydrogenation attempts and Parr Bomb conditions 
 
In a happy discovery, a hitherto unknown piece of equipment in the lab was 
revealed to be a Parr bomb, a specialized piece of laboratory equipment that is designed 
for reactions that need to be run under high pressure, temperature, or both. In the light of 
this discovery, a compressed gas cylinder of H2 was used to pressurize the bomb containing 
Raney Nickel and the ester in absolute methanol to 60 psi (~4 atm) and heated to 65˚C in 
a sand bath for 12 hours. The crude NMR showed an almost complete conversion of the 
ester to the lactam hoped for. Knowing that the following steps would be intolerant of the 
amide proton, the nitrogen was then protected with a tert-butyloxycarbonyl group (Boc) 
succinctly.  
After conducting a thorough literature search, several options were considered 
viable for installing the α-hydroxy moiety, the three likeliest candidates being oxaziridines, 
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molecular oxygen, and oxodiperoxymolybdenum(pyridine)-(hexamethylphosphoric 
triamide) (MoOPH), in order of gauged success. Each of the reagents acts as an 
electrophilic source of oxygen, meaning that each of the reactions would require forming 
the enolate from the lactam. Since it was judged to be the most likely to succeed, the first 
to be attempted was the use of an oxaziridine, namely Davis’ sulfonyloxaziridine.  
 
Figure 2.12 Possible α-hydroxylation reagents, and attempted conditions 
 
Gratifyingly, Davis’s reagent appeared to work on the first attempt, and the α-
hydroxy amide was purified in a 30% yield, a result that has since been difficult to 
recapitulate, which is discussed in further detail further in the chapter. Having isolated the 
alcohol, the final step to PMFTH2 was the removal of the methoxy and Boc protecting 
groups. For this a traditional approach with BBr3 was used, and was adequate in removing 
 
 70 
both protecting group in a matter of hours at 0˚C. 1H, 13C, and 2D experiments were used 
to verify the product, which was further confirmed by the exact HRMS mass.  
With this success in hand, the synthesis was reattempted in order to build up further 
stock and to attempt further reactions, such as the oxidation of PMFTH2 to PMFT, forming 
the α-ketoamide. To this end, starting material was synthesized and accumulated up to the 
Boc protected amide. From this point however, there were difficulties in recapturing the 
initial success of installing the α-hydroxy moiety. 
 
Figure 2.13 Modified completed route to MFT 
 
The first issue was the purification of the product from the byproducts formed as a 
result of using Davis’s reagent, namely sulfonamides and imines. Successive columns and 
attempted recrystallizations summarily resulted in a loss of product. In addition to this, 
starting material was continuously recovered in ever greater amounts. In order to address 
this issue, several different amide bases were screened, such as LDA, LiEt2N, LiTMP, 
LiHMDS, and KHMDS. The THF was used was further dried, and it was ensured that all 
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reagents being utilized were purified. Observing a continuation in the trend lead to the 
conclusion that the Davis’s reagent had simply decomposed over time, which led to 




Figure 2.14 Proton and Carbon NMR of PMFT 
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First attempted was the use of molecular oxygen, as that had been successfully used 
by other groups with similar substrates,129, 130 however this showed no observable 
conversion of starting material into either the alcohol or hydroperoxide. A slightly different 
oxaziridine was then explored, based on camphorsulfonic acid as opposed to tosic acid. 
This reagent has found much use as a reagent for asymmetric hydroxylation, however is 
also known to be more bench stable and usable than its tosic acid analogue.131 With this in 
hand, there has been some initial success in installing the alcohol, as determined by NMR.  
2.3 Future directions 
 
With a route now available to PMFTH2, there are several options that can be further 
explored. Firstly, is to explore oxidation methods to yield PMFT. For this, it is anticipated 
that traditional oxidation methods that selectively react with alcohols over benzylic protons 
will succeed, such as a Swern Oxidation132 or Dess-Martin periodinane, among others. 
Following this optimization, analogs of PMFT and PMFTH2 can be synthesized in order 
to probe MFT’s molecular function and possible therapeutic uses. Examples of these 
analogues are shown in Figure 2.15.  
While there is more synthetic work required to access PMFT and MFT itself, 
having elucidated a synthetic route to PMFTH2 grants access to those molecules, in 
addition to a variety of yet untested analogues. As a novel RiPP with unexplored 
significance within M. tuberculosis, synthetic MFT will be a tool to leverage more 











(E)-1-methoxy-4-(2-nitrovinyl)benzene (1):  To a mixture of 4-methoxybenzaldehyde 
(15 g, 110 mmol, 1 eq.) in 200 ml of methanol was added nitromethane (5.9 ml, 110 mmol, 
1.0 eq.) and the reaction was mixture was cooled to -10 oC. NaOH (5.28 g, 145 mmol, 1.2 
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eq.) was added slowly into the reaction mixture through an addition funnel. The reaction 
mixture was stirred at this temperature for 1.5 h. Upon completion monitored by TLC, the 
mixture was neutralized with 4 M HCl to form a yellow precipitate. The precipitate was 
filtered and dried to afford the desired product as a yellow solid, yield 96% (19g).  
1H NMR (500 MHz, CDCl3) δ8.01 (d, J = 13.6 Hz, 1H), 7.58 – 7.51 (m, 3H), 6.98 (d, J = 
8.9 Hz, 2H), 3.90 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ162.96, 139.08, 135.05, 131.20, 122.57, 114.95, 55.56. 
1-methoxy-4-(2-nitroethyl)benzene (2): 1 (14.9 g, 83 mmol, 1 eq.) was added to a stirred 
suspension of silica (150 g, 60 Å, 230-400 mesh, Silicyle) in a mixture of chloroform (200 
mL) and isopropyl alcohol (60 ml) at 25 oC.  The resulting yellow mixture was cooled to 0 
oC, and sodium borohydride (6.9g, 182.6 mmol, 2.2 eq.) was added slowly over 30 min. 
The resulting mixture was then stirred vigorously at this temperature for additional 30 min. 
The mixture was allowed to warm to 25 oC and allowed to stir at this temperature for 30 
additional min. The suspension was cooled to 0 oC and aqueous solution of hydrochloric 
acid (0.2 M) was added slowly until no gas evolution was observed. The resulting mixture 
was filtered, and the residue was washed with dichloromethane (150 ml). The filtrate was 
washed with water (200 ml), the aqueous phase was extracted with dichloromethane (3 x 
50 ml) and the organic phases were pooled together, washed with brine (2 x 50 ml), and 
dried over anhydrous sodium sulfate. The dried solution was filtered and concentrated 
under vacuum to afford the desired product as a reddish oil, yield 94% (14.2 g). 
1H NMR (500 MHz, CDCl3) δ 7.15 (d, J = 8.6 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 4.60 (t, J 
= 7.4 Hz, 2H), 3.81 (s, 3H), 3.28 (t, J = 7.4 Hz, 2H). 
13C NMR (126 MHz, CDCl3) δ 158.89, 129.66, 127.64, 114.33, 76.61, 55.27, 32.68 
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5-(4-methoxybenzyl)-4,4-dimethylpyrrolidin-2-one (3):  To a mixture of ethyl 3-
methylbut-2-enoate (5 g, 39 mmol, 1 eq.) in tetra-n-butylammonium fluoride in THF (40 
ml, 1 M 1 eq.) was added 2 (7.1 g, 39 mmol, 1 eq.) and the reaction was stirred at 40 oC 
for 24 hours. The mixture was treated with brine and the aqueous phase was extracted with 
ether. The organic phase was concentrated under vacuum and purified by chromatography 
on silica gel to afford ethyl 5-(4-methoxyphenyl)-3,3-dimethyl-4-nitropentanoate, yield 
33% (4 g).  
1H NMR (500 MHz, CDCl3) δ 7.10 (d, J = 8.5 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 4.94 (dd, 
J = 11.9, 2.5 Hz, 1H), 4.20 (qd, J = 7.1, 5.5 Hz, 2H), 3.79 (s, 3H), 3.22 (dd, J = 14.5, 11.9 
Hz, 1H), 3.06 (dd, J = 14.4, 2.5 Hz, 1H), 2.45 (s, 2H), 1.31 (t, J = 7.1 Hz, 3H), 1.27 (s, 3H), 
1.22 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 170.74, 158.77, 129.78, 128.05, 114.20, 97.38, 60.61, 
55.17, 43.44, 36.52, 33.52, 24.35, 23.90, 14.25. 
5-(4-methoxybenzyl)-4,4-dimethylpyrrolidin-2-one (4a): Into a 25 mL round bottom 
flask Raney Nickel (~1 g, 2800 Ni slurry in H2O) was added, and washed 3 times with 
absolute methanol before a solution of 3 (560 mg, 1.8 mmol) in methanol (2 mL) was 
added. Absolute methanol was added until total volume was approximately 10 mL, and the 
open flask placed in sand within a Parr bomb. The bomb was sealed and pressurized to 65 
psi with ultrapure H2 gas, and subsequently heated to 60˚C for 12 hours. At this time the 
apparatus was cooled to room temperature, depressurized, and the suspension filtered 
through a Celite plug while washing with methanol. The reaction mixture was concentrated 
in vacuo, and the resulting clear oil was clean enough to use without further purification. 
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For further purification, the crude mixture was subjected to silica flash chromatography to 
yield product as a white crystal (237 mg, 56%).  
1H NMR (500 MHz, CDCl3) δ 7.09 (d, J = 8.5 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 5.27 (s, 
1H), 3.80 (s, 3H), 3.41 (dd, J = 11.4, 3.2 Hz, 1H), 2.80 (dd, J = 13.5, 3.2 Hz, 1H), 2.42 (dd, 
J = 13.5, 11.4 Hz, 1H), 2.21 (s, 2H), 1.20 (s, 3H), 1.14 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 176.34, 158.53, 130.15, 129.80, 114.37, 65.33, 55.33, 
46.16, 38.41, 35.91, 27.43, 22.92. 
tert-butyl 2-(4-methoxybenzyl)-3,3-dimethyl-5-oxopyrrolidine-1-carboxylate (4b): 
Compound 4a (186 mg, 0.8 mmol, 1 eq.) was dissolved in degassed DCM, and Boc2O (435 
mg, 2 mmol, 2.5 eq.), anhydrous triethylamine (0.24 mL, 1.6 mmol, 2 eq.), and DMAP 
(117 mg, 0.96 mmol, 1.2 eq.) were sequentially added. The suspension was stirred at room 
temperature for 4 hours, then brought to reflux for 1 hour, after which the suspension was 
cooled to room temperature. Boc2O (175 mg, 0.8 mmol, 1 eq.) and triethylamine (0.1 mL, 
0.8 mmol, 1 eq.) were added, and the solution was stirred at room temperature until TLC 
indicated the consumption of starting material. The solution was extracted with DCM, 
washed with brine (3x), and dried with Na2SO4. The crude material was purified by silica 
flash chromatography (MeOH/DCM) to yield 5b as a colorless crystal (238 mg, 90%).  
1H NMR (500 MHz, CDCl3) δ 7.15 (d, J = 8.6 Hz, 2H), 6.85 (d, J = 8.5 Hz, 2H), 4.05 (t, J 
= 6.5 Hz, 1H), 3.80 (s, 3H), 2.92 (dd, J = 14.2, 7.1 Hz, 1H), 2.81 (dd, J = 14.2, 5.9 Hz, 1H), 
2.44 (d, J = 17.0 Hz, 1H), 2.13 (d, J = 17.0 Hz, 1H), 1.43 (s, 9H), 1.14 (s, 3H), 1.10 (s, 3H).  
13C NMR (126 MHz, CDCl3) δ 173.52, 158.24, 150.02, 130.35, 129.78, 113.95, 82.59, 




carboxylate (5): A solution of 4b (240 mg, 0.72 mmol, 1 eq.) in degassed THF (8 mL) 
was cooled to -78˚C, and a solution of freshly prepared LDA (0.8 mL, 1.7 M in THF, 2 
eq.) was added dropwise. The suspension was stirred for 15 minutes at -78˚C, then warmed 
to 0˚C for 1 hour. Cooling back to -78˚C, a solution of Davis’ Oxaziridine (244 mg, 0.93 
mmol, 1.3 eq.) in THF (1 M) was added dropwise. The suspension was stirred for 1 hour 
at -78˚C, and 2 hours at -40˚C, at which point it was quenched with NH4Cl (aq.) and 
allowed to warm to room temperature. The solution was extracted with Et2O, washed with 
brine (3x) and dried with MgSO4. 7 was obtained following purification with silica flash 
chromatography (MeOH/DCM) 75 mg (30%).  
1H NMR (500 MHz, CDCl3) δ 7.21 (d, J = 8.4 Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 4.01 (dd, 
J = 9.4, 4.4 Hz, 1H), 3.82 (s, 3H), 3.41 (dd, J = 14.1, 4.5 Hz, 1H), 2.84 (dd, J = 14.1, 9.4 
Hz, 1H), 2.66 (s, 1H), 1.52 (s, 9H), 1.05 (s, 3H), 0.90 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 174.67, 158.21, 150.03, 130.29, 130.15, 113.98, 83.61, 
78.77, 66.50, 55.26, 39.66, 35.39, 27.95, 26.41, 16.27.  
3-hydroxy-5-(4-hydroxybenzyl)-4,4-dimethylpyrrolidin-2-one (6): To a solution of 5 
(70 mg, 0.2 mmol, 1 eq.) in DCM (1.5 mL) was added BBr3 (1 mL, 1 M in DCM, 5 eq.) at 
0˚C. The resulting solution was stirred for 3 hours at 0˚C, after which time TLC indicated 
the consumption of starting material. Following a careful quench with NaHCO3 (aq.), the 
solution was extracted with EtOAc, washed with brine (3x) and dried with MgSO4. The 
compound of interest was obtained following flash chromatography on silica (5% 
MeOH/DCM). 16.5 mg, 35%.  
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1H NMR (500 MHz, CDCl3) δ 7.54 (s, 1H), 7.03 (d, J = 8.4 Hz, 2H), 6.83 (d, J = 8.5 Hz, 
2H), 5.48 (s, 1H), 3.96 (d, J = 2.3 Hz, 1H), 3.40 (dd, J = 11.1, 3.4 Hz, 1H), 2.97 (s, 1H), 
2.80 (dd, J = 13.8, 3.4 Hz, 1H), 2.43 (dd, J = 13.9, 11.1 Hz, 1H), 1.25 (s, 3H), 0.98 (s, 3H). 
13C NMR (126 MHz, DMSO) δ 175.82, 156.12, 130.30, 129.04, 115.59, 78.07, 60.62, 
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